Presentation TCT 2023 Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions Presenter: Andrew Sharp October 23, 2023
Presentation TCT 2023 The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective Presenter: Dana Asato October 23, 2023
Presentation TCT 2023 Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies Presenter: Peter Monteleone October 23, 2023
News Daily News Study Finds No Increased Risk of CVD Years After Infertility Therapies L.A. McKeown August 11, 2023
News Daily News Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism Caitlin E. Cox June 16, 2023
News Conference News SCAI 2023 FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy L.A. McKeown May 21, 2023
News Daily News Similarly Low Risk of CV Events With Bivalent and Monovalent mRNA Boosters Shelley Wood March 29, 2023
News Daily News Prehospital Troponin Testing With EMS Input Could Save a Lot of Money Michael O'Riordan February 07, 2023
News Daily News RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads Todd Neale January 19, 2023
News Daily News PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures L.A. McKeown January 18, 2023
News Daily News CV Risk After Acute COVID-19 Not So High as Feared: Registry Todd Neale January 06, 2023
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
Presentation TCT 2022 Getting Smart With PE Diagnosis: The Role of AI Presenter: Robert Lookstein September 19, 2022